| Improving Anticoagulation Control in VISN 1 (NCT01653405) | VA Office of Research and Development | 2014-10-01 |
| Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty (NCT02271399) | Hanyang University Seoul Hospital | 2014-10-01 |
| Safety of Dabigatran Etexilate in Blood Clot Prevention in Children (NCT02197416) | Boehringer Ingelheim | 2014-09-29 |
| Tolerability , PK/PD and Safety of Dabigatran Etexilate Oral Liquid Formulation in Children < 1 Year of Age (NCT02223260) | Boehringer Ingelheim | 2014-09-01 |
| Description of Patients With Acute Venous Thromboembolism in the UK's Clinical Practice Research Datalink Linked With Hospital Episode Statistics Dataset (CPRD-HES) (NCT02661568) | Bristol-Myers Squibb | 2014-09-01 |
| A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill Patients (NCT02213978) | Beijing Chao Yang Hospital | 2014-08-01 |
| Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events (NCT02155491) | Thrombosis Research Institute | 2014-07-07 |
| Eliquis Regulatory Post Marketing Surveillance (rPMS) (NCT01885585) | Bristol-Myers Squibb | 2014-07-01 |
| Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs (NCT02066454) | University Hospital, Grenoble | 2014-06-05 |
| Validation of the 4TS RAM in the Prevention of Venous Thromboembolism in Patients With Plasma Cell Dyscrasias. (NCT03405571) | University of Athens | 2014-06-01 |
| ODEN Trial: Option vs. Denali IVC Filters (NCT02201277) | University of California, San Francisco | 2014-05-27 |
| Educating Nurses About Venous Thromboembolism (VTE) Prevention (NCT02301793) | Johns Hopkins University | 2014-04-01 |
| Apixaban for the Prevention of Venous Thromboembolism in Cancer Patients (NCT02048865) | Ottawa Hospital Research Institute | 2014-03-24 |
| Pharmacokinetics of Enoxaparin in Intensive Care Patients (NCT02095509) | Tampere University Hospital | 2014-03-01 |
| Bemiparin Versus Enoxaparin in the Prevention of Venous Thromboembolism Among ICU Patients (NCT02795065) | Mohamed Sayed Mohamed Abbas | 2014-03-01 |
| Single Session Percutaneous Mechanical Thrombectomy for the Treatment of Ilio-femoral Deep Vein Thrombosis: A Preliminary Evaluation (NCT02066597) | Ottawa Hospital Research Institute | 2013-11-01 |
| Angel® Catheter Early Feasibility Clinical Study (NCT01847196) | BiO2 Medical | 2013-11-01 |
| Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE) (NCT01895777) | Boehringer Ingelheim | 2013-09-25 |
| Risk of Recurrent Venous Thrombosis: A Validation Study of the Vienna Prediction Model (NCT01972243) | Medical University of Vienna | 2013-09-01 |
| Prospective Study on Preoperative Versus Postoperative Venous Thromboprophylaxis in Patients Undergoing Major Colorectal Surgery (NCT01976988) | Cedars-Sinai Medical Center | 2013-09-01 |
| Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery (NCT01431456) | Martini Hospital Groningen | 2013-09-01 |
| Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxis (NCT02070237) | MemorialCare Health System | 2013-08-01 |
| Feasibility Study of Geko vs. IPCs in Trauma (NCT01835990) | Hamilton Health Sciences Corporation | 2013-07-01 |
| Weight Based Enoxaparin in Trauma Patients (NCT01916707) | Intermountain Health Care, Inc. | 2013-07-01 |
| Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants (NCT02185027) | University Hospital, Grenoble | 2013-06-01 |
| Long-term Surveillance of Patients With Venous Thromboembolism: a Nationwide Prospective Cohort Study (NCT06073366) | China National Center for Cardiovascular Diseases | 2013-05-01 |
| Reproducibility of Plasma Nucleosomes and Free DNA as Markers for Venous Thromboembolism (NCT01559207) | Centre Hospitalier Universitaire de Nīmes | 2013-04-01 |
| Incidence of Venous Thromboembolism and Professional Practices in Brest Area (NCT02895971) | University Hospital, Brest | 2013-03-04 |
| Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant (NCT02079584) | Indiana University | 2013-03-01 |
| Venous Thromboembolism Prophylaxis in Medical and Surgical ICUs in a Single University Hospital (NCT01851239) | Yonsei University | 2013-02-01 |
| Identification of New Genetic Markers of Risk of Venous Thromboembolism Recurrence by Analyzing Whole Genome (NCT02904967) | Assistance Publique Hopitaux De Marseille | 2013-01-18 |
| Venous Thromboembolism Prophylaxis in a Tertiary UAE Hospital: Comparison of Clinical Practice Guidelines. (NCT01958203) | Ministry of Health, United Arab Emirates | 2013-01-01 |
| Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of Age (NCT01773174) | Boehringer Ingelheim | 2013-01-01 |
| Can Thrombin Generation Measurement Predict the Risk of Venous Thromboembolism in Acute Ill Patients (NCT01744431) | HaEmek Medical Center, Israel | 2012-12-01 |
| Effectiveness And Safety of LMWH Treatment in Cancer Patients Diagnosed With Non-High Risk Venous Thromboembolism (NCT02017743) | Trio Grup Clinical Research | 2012-12-01 |
| Predictive Value of Whole Blood Coagulation Parameters for Post-discharge Venous Thromboembolism After Cancer Resection (NCT01608919) | University of Colorado, Denver | 2012-11-01 |
| Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer (NCT01803022) | LEO Pharma | 2012-11-01 |
| Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients (NCT01602432) | Ottawa Hospital Research Institute | 2012-11-01 |
| Active Comparator-Controlled Study to Assess Safety and Efficacy of ISIS-FXIRx in Total Knee Arthroplasty (NCT01713361) | Ionis Pharmaceuticals, Inc. | 2012-10-01 |
| Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism (NCT01602445) | Ottawa Hospital Research Institute | 2012-07-01 |
| Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts (NCT01598805) | University of Zurich | 2012-06-01 |
| PREvention of VENous Thromboembolism In Hemorrhagic Stroke Patients (NCT01573169) | University Of Perugia | 2012-05-01 |
| Efficacy of RIvaroxaban for Prevention of Venous Thromboembolism After Knee Arthroscopy (NCT01629381) | University of Padova | 2012-05-01 |
| Collaborative Healthcare Professionals Approach in Monitoring of Patient Centered Outcomes Through Pathways (NCT01561885) | Majed Aljeraisy | 2012-03-01 |
| Safety and Pharmacokinetics Study of DU-176b Administered to Patients With Severe Renal Impairment Undergoing Orthopedic Surgery of The Lower Limbs (NCT01857583) | Daiichi Sankyo Co., Ltd. | 2012-03-01 |
| Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE) (NCT01524653) | University of Vermont | 2012-03-01 |
| Safety Study of the Angel™ Catheter in Subjects With Risk of Pulmonary Embolism (NCT01403090) | BiO2 Medical | 2011-12-01 |
| Fondaparinux in Critically Ill Patients With Renal Failure (NCT01467583) | Wayne State University | 2011-11-01 |
| Optimal Prophylactic Method of Venous Thromboembolism (VTE) (NCT01448746) | The Catholic University of Korea | 2011-10-01 |
| START-Register: Survey on Anticoagulated Patients Register (NCT02219984) | GUALTIERO PALARETI | 2011-10-01 |
| Systematic Review and Meta-Analysis of Venous Thromboembolism (VTE) Risk Assessment in Hospitalized Medical Patients (NCT01446510) | Intermountain Health Care, Inc. | 2011-09-01 |
| Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE) (NCT01357941) | Hamilton Health Sciences Corporation | 2011-09-01 |
| Anti Xa Activity in Cancer Patients Receiving Low-molecular-weight Heparin for Venous Thromboembolism (NCT02898051) | Assistance Publique - Hôpitaux de Paris | 2011-08-01 |
| Multiple-Dose Study Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter (NCT01195727) | Bristol-Myers Squibb | 2011-07-26 |
| Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese Patients (NCT01363193) | Nazareth Hospital | 2011-07-01 |
| National Evaluation of the Adherence to Recommendations of Venous Thrombo Embolism Treatment in Cancer Patients (NCT01362933) | Floralis | 2011-05-01 |
| ICU Venous Thromboembolism Incidence Study in a Chinese Population (NCT01504087) | National Taiwan University Hospital | 2011-05-01 |
| Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist (NCT01348074) | McMaster University | 2011-04-01 |
| Multicenter Registry for Effectiveness Analysis of ActiveCare+S.F.T® Mobile Compression Device for Thrombosis Prevention in Hip and Knee Arthroplasty (NCT01984190) | Medical Compression Systems | 2011-04-01 |
| Electronic Strategies to Enhance Venous Thromboemboli (VTE) Prophylaxis in Hospitalized Medical Patients (NCT01401725) | McMaster University | 2011-04-01 |
| Compression Treatment Effects on Complications and Healing of Achilles Tendon Rupture (NCT01317160) | Karolinska University Hospital | 2011-03-01 |
| PROSPER: PostpaRtum PrOphylaxiS for PE Randomized Control Trial Pilot (NCT01274637) | Ottawa Hospital Research Institute | 2011-03-01 |
| EUropean Pharmacogenetics of AntiCoagulant Therapy - Warfarin (NCT01119300) | Utrecht Institute for Pharmaceutical Sciences | 2011-01-01 |
| Coagulation After Intravenous Methylprednisolone Administration (NCT03535090) | Piotr Miskiewicz | 2011-01-01 |
| Venous Thromboembolism Prophylaxis Post Cesarean Section (NCT01321788) | King Saud University | 2011-01-01 |
| The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery (NCT01267305) | Shanghai Zhongshan Hospital | 2011-01-01 |
| Evaluation of Oral Anticoagulation With Vitamin K Antagonists - The thrombEVAL Study Programme (NCT01809015) | Johannes Gutenberg University Mainz | 2011-01-01 |
| Explicit Assessment of Thromboembolic Risk and Prophylaxis for Medical Patients in Switzerland (NCT01277536) | University Hospital, Geneva | 2010-12-01 |
| Graduated Compression Stockings (GCS) Pilot Substudy (NCT01234064) | Hamilton Health Sciences Corporation | 2010-11-01 |
| EUropean Pharmacogenetics of AntiCoagulant Therapy - Acenocoumarol (NCT01119261) | Utrecht Institute for Pharmaceutical Sciences | 2010-11-01 |
| Study in Healthy Volunteers of the Reversion by Haemostatic Drugs of the Anticoagulant Effect of New Anti-thrombotics (NCT01210755) | University Hospital, Grenoble | 2010-11-01 |
| Dose-confirmatory Bridging Study in Total Knee Replacement (NCT01206972) | Bayer | 2010-10-01 |
| Dose-confirmatory Bridging Study in Total Hip Replacement (NCT01205932) | Bayer | 2010-09-01 |
| Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer (NCT01130025) | LEO Pharma | 2010-08-01 |
| Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism (NCT01164046) | University Medical Center Groningen | 2010-08-01 |
| Pradaxa (Dabigatran Etexilate) VTE Prevention After Elective Total Hip or Knee Replacement Surgery (NCT01153698) | Boehringer Ingelheim | 2010-08-01 |
| Filter Initial & Long Term Evaluation After Placement and Retrieval Registry (NCT01158482) | Stanford University | 2010-06-01 |
| Incidence of Venous Thromboembolism Following Surgery in Patients With Gastric Cancer (NCT01345773) | Seoul National University Bundang Hospital | 2010-05-01 |
| Efficacy of Sodium Heparin in Prophylaxis of Venous Thromboembolism in Surgical Patients (NCT00912483) | Azidus Brasil | 2010-05-01 |
| Efficacy of Sodium Heparin for Prophylaxis of Venous Thromboembolism in Surgical Patients (NCT00934167) | Azidus Brasil | 2010-05-01 |
| Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients (NCT00966277) | M.D. Anderson Cancer Center | 2010-04-01 |
| The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma (NCT01050153) | Denver Health and Hospital Authority | 2010-03-01 |
| An Observational Study On The Safety And Tolerability Of Prolonged Thrombosis Prophylaxis With Fragmin® (NCT01046903) | Pfizer | 2010-03-01 |
| Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age (NCT01083732) | Boehringer Ingelheim | 2010-03-01 |
| Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism (NCT01004939) | GlaxoSmithKline | 2010-03-01 |
| Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study (NCT03292666) | University of California, San Francisco | 2010-01-01 |
| Xarelto Regulatory Post-Marketing Surveillance (NCT01029743) | Bayer | 2009-12-01 |
| A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis (NCT00789399) | Prairie Education and Research Cooperative | 2009-11-19 |
| Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis (NCT00790335) | Washington University School of Medicine | 2009-11-01 |
| Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI) (NCT01014403) | University of Texas Southwestern Medical Center | 2009-11-01 |
| Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study). (NCT00986154) | Daiichi Sankyo | 2009-10-01 |
| The Swiss Venous Thromboembolism Cohort 65+ (NCT00973596) | University of Lausanne Hospitals | 2009-09-01 |
| Remote Home Prothrombin Time (PT)/International Normalized Ratio (INR) Monitoring and Patient Management System (NCT00978445) | ZIN Technologies, Inc. | 2009-09-01 |
| Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients (NCT00952380) | Pfizer | 2009-08-01 |
| A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients (NCT00876915) | University of Rochester | 2009-07-01 |
| Safety and Tolerability of Dabigatran Etexilate in Adolescents (NCT00844415) | Boehringer Ingelheim | 2009-06-01 |
| Prevention of Recurrence of Venous Thromboembolism in Patients With a History of Venous Thromboembolism (NCT00937820) | Astellas Pharma Inc | 2009-06-01 |
| Prevention of Venous Thromboembolism in Subjects Undergoing Hip Fracture Surgery or Surgery in the Lower Extremities (NCT00937911) | Astellas Pharma Inc | 2009-06-01 |
| Cancer Patients Diagnosed With Unsuspected Venous Thromboembolism (VTE) on Routine Computed Tomography (CT) Scans (NCT00925808) | M.D. Anderson Cancer Center | 2009-06-01 |
| A Study to Assess the Effect of YM150 for Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery (NCT00942435) | Astellas Pharma Inc | 2009-06-01 |